Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifonazole vs Placebo After Nail Ablation for Onychomycosis
NCT00781820Phase 3Completed
- Sponsor
- Bayer
- Start
- Oct 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in onychomycosis comparing Bifonazole with Placebo (2 arms). Primary endpoint: Overall cure rate comprising clinical cure and mycological cure. Started Oct 2008; status: completed.
02
Drugs
bifonazole
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT00781820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00781820.